KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Enterprise Value (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Enterprise Value for 16 consecutive years, with -$88.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 14.97% to -$88.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$88.9 million, a 14.97% increase, with the full-year FY2025 number at -$88.9 million, up 14.97% from a year prior.
  • Enterprise Value was -$88.9 million for Q4 2025 at Biolife Solutions, down from -$79.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$19.1 million in Q1 2023 to a low of -$104.6 million in Q4 2024.
  • A 5-year average of -$58.3 million and a median of -$62.2 million in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: crashed 1291.64% in 2021, then skyrocketed 68.73% in 2023.
  • Biolife Solutions' Enterprise Value stood at -$69.9 million in 2021, then rose by 10.26% to -$62.7 million in 2022, then increased by 29.53% to -$44.2 million in 2023, then plummeted by 136.7% to -$104.6 million in 2024, then grew by 14.97% to -$88.9 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Enterprise Value are -$88.9 million (Q4 2025), -$79.0 million (Q3 2025), and -$81.8 million (Q2 2025).